IL37 and atherosclerosis: Studies have revealed that the concentration of IL-37 increases significantly in the foam or macrophage cells of the atherosclerotic plaque, suggesting that IL-37 released from the atherosclerotic lesion to the blood may play a protective role in the development of atherosclerosis [119–121].